Total Payments
$3,509
2024 Payments
$1,352
Companies
17
Transactions
114
Medicare Patients
5,227
Medicare Billing
$848,595
Payment Breakdown by Category
Food & Beverage$3,343 (95.3%)
Education$165.99 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,343 | 109 | 95.3% |
| Education | $165.99 | 5 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $593.38 | 20 | $0 (2024) |
| ViiV Healthcare Company | $585.36 | 17 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $563.53 | 24 | $0 (2024) |
| Astellas Pharma US Inc | $359.50 | 14 | $0 (2024) |
| ABBVIE INC. | $255.24 | 7 | $0 (2024) |
| Insmed, Inc. | $233.50 | 5 | $0 (2024) |
| Theravance Biopharma, Inc. | $232.27 | 6 | $0 (2018) |
| Shionogi Inc | $150.28 | 3 | $0 (2024) |
| Allergan Inc. | $128.97 | 2 | $0 (2017) |
| La Jolla Pharmaceutical Company | $88.63 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,352 | 53 | Astellas Pharma US Inc ($309.19) |
| 2023 | $677.64 | 26 | Gilead Sciences, Inc. ($347.64) |
| 2022 | $424.65 | 14 | Paratek Pharmaceuticals, Inc. ($237.44) |
| 2021 | $107.10 | 4 | La Jolla Pharmaceutical Company ($68.00) |
| 2020 | $24.97 | 2 | Paratek Pharmaceuticals, Inc. ($17.04) |
| 2019 | $561.77 | 7 | ViiV Healthcare Company ($208.85) |
| 2018 | $232.27 | 6 | Theravance Biopharma, Inc. ($232.27) |
| 2017 | $128.97 | 2 | Allergan Inc. ($128.97) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: HIV | ||||||
| 12/18/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 12/12/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $65.00 | General |
| Category: Infectious Diseases | ||||||
| 11/19/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: HIV | ||||||
| 11/18/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: HIV | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: Infectious Diseases | ||||||
| 11/05/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $1.92 | General |
| Category: ANTIBIOTIC | ||||||
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.98 | General |
| 10/15/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 10/10/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: HIV | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: Infectious Diseases | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Infectious Diseases | ||||||
| 09/24/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $34.75 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.66 | General |
| 08/14/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $31.50 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: ANTIBIOTIC | ||||||
| 07/30/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.78 | General |
| Category: HIV | ||||||
| 07/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: GI | ||||||
| 07/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: ANTIBIOTIC | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Infectious Diseases | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $1.89 | General |
| Category: Infectious Diseases | ||||||
| 07/01/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $58.80 | General |
| Category: Infections and Infectious Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,103 | 2,403 | $415,760 | $233,281 |
| 2022 | 8 | 1,344 | 2,478 | $394,285 | $203,150 |
| 2021 | 9 | 1,411 | 2,565 | $383,800 | $189,349 |
| 2020 | 10 | 1,369 | 2,663 | $419,290 | $222,814 |
Total Patients
5,227
Total Services
10,109
Medicare Billing
$848,595
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 406 | 1,526 | $228,900 | $142,591 | 62.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 400 | 435 | $130,500 | $58,664 | 45.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 93 | $13,020 | $8,936 | 68.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 104 | $10,920 | $6,602 | 60.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 54 | 98 | $11,270 | $6,053 | 53.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 62 | 90 | $8,550 | $3,485 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 22 | $3,850 | $3,018 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,250 | $2,108 | 49.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,500 | $1,824 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 387 | 427 | $128,100 | $66,876 | 52.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 281 | 717 | $107,550 | $58,435 | 54.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 314 | 744 | $85,560 | $42,087 | 49.2% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 150 | 302 | $28,690 | $9,276 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 129 | $13,545 | $9,091 | 67.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 56 | 81 | $11,340 | $8,288 | 73.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 47 | 48 | $12,000 | $5,163 | 43.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $7,500 | $3,936 | 52.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 390 | 973 | $111,895 | $56,381 | 50.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 240 | 560 | $84,000 | $46,636 | 55.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 383 | 410 | $102,500 | $44,700 | 43.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 76 | 79 | $23,700 | $12,688 | 53.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 169 | 319 | $30,305 | $9,894 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 110 | $11,550 | $7,522 | 65.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 67 | $9,380 | $6,998 | 74.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 32 | 32 | $6,720 | $2,605 | 38.8% |
About Dr. Wesley Emmons, M.D
Dr. Wesley Emmons, M.D is a Infectious Disease healthcare provider based in Newark, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770692782.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wesley Emmons, M.D has received a total of $3,509 in payments from pharmaceutical and medical device companies, with $1,352 received in 2024. These payments were reported across 114 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,343).
As a Medicare-enrolled provider, Emmons has provided services to 5,227 Medicare beneficiaries, totaling 10,109 services with total Medicare billing of $848,595. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Newark, DE
- Active Since 08/30/2006
- Last Updated 01/31/2008
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1770692782
Products in Payments
- NUZYRA (Drug) $563.53
- DOVATO (Drug) $352.38
- VIBATIV (Drug) $270.92
- DALVANCE (Drug) $238.26
- Arikayce (Drug) $233.50
- Cresemba (Drug) $205.53
- Fetroja (Drug) $150.28
- CABENUVA (Biological) $129.59
- TEFLARO (Drug) $123.34
- Epclusa (Drug) $115.00
- RUKOBIA (Drug) $103.39
- XERAVA (Drug) $88.63
- Xerava (Drug) $73.18
- VOWST (Biological) $71.89
- EGRIFTA (Drug) $51.75
- Veklury (Drug) $32.08
- PREVYMIS (Drug) $27.58
- PIFELTRO (Drug) $23.06
- AVYCAZ (Drug) $22.61
- ULTOMIRIS (Biological) $19.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Newark
Dr. Jihad Slim, Md, MD
Infectious Disease — Payments: $2.2M
Infectious Disease $2.2M
Dr. Maria Szabela, Md, MD
Infectious Disease — Payments: $336,664
Infectious Disease $336,664
Sally Hodder, M.d, M.D
Infectious Disease — Payments: $93,382
Infectious Disease $93,382
Shobha Swaminathan, M.d, M.D
Infectious Disease — Payments: $78,788
Infectious Disease $78,788
Wanda Figueroa, M.d, M.D
Infectious Disease — Payments: $13,660
Infectious Disease $13,660
Alexander Stoler, M.d, M.D
Infectious Disease — Payments: $5,931
Infectious Disease $5,931